Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Generic Health Pty Ltd v Bayer Pharma Aktiengesellschaft [2018] FCAFC 183 Appeal from: Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 250; 124 IPR 23 Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 428
File number: NSD 717 of 2017
Judges: ALLSOP CJ, YATES AND BEACH JJ
Date of judgment: 24 October 2018
Catchwords: PATENTS – infringement – pharmaceutical product – oral contraceptive – combination of ethinylestradiol and drospirenone – s 115(1)(a) of Patents Act 1990 (Cth) – whether specification framed in good faith and with reasonable skill and knowledge – corporate patentee – drafter taken to have patentee's knowledge – knowledge patentee reasonably should be taken to have had DAMAGES – loss of profits on lost sales – quantification of damages – compensatory – estimation – probabilities of hypothetical counterfactual – loss of opportunity – value of loss of opportunity – whether sale of each infringing product resulted in a lost sale of patented product – uncertainty – appropriate discount – whether other oral contraceptives substitutable – five-step methodology – price depression – sale of patentee's own generic product – reasonable response by patentee – causation – remoteness – relevant sales period to address price depression – pre-judgment interest – interest assessed on pre-tax loss – indemnity costs – r 25.14(3) of Federal Court Rules 2011 (Cth) – appeal allowed in part
Legislation: Federal Court of Australia Act 1976 (Cth), s 28 Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth) Letters Patent for Invention Act 1835 (UK), s 1 (repealed) Patent Law Amendment Act 1852 (UK) (repealed) Patents Act 1899 (NSW), s 19 (repealed) Patents Act 1889 (Vic), s 26 (repealed) Patents Act 1903 (Cth), s 82 (repealed) Patents Act 1949 (UK), s 59(3) (repealed) Patents Act 1952 (Cth), ss 87 (repealed), 159B (repealed) Patents Act 1962 (Cth), s 17 (repealed) Patents Act 1969 (Cth), s 35 (repealed) Patents Act 1977 (UK), ss 62(3), 63(2) Patents Act 1990 (Cth), ss 40(2)(a), 40(3), 115(1)(a), 138(3)(e) Patents Amendment Act 1979 (Cth), s 66 (repealed) Patents and Designs Act 1907 (UK), s 23 (repealed) Patents and Designs Act 1932 (UK) (repealed) Patents, Designs, and Trade Marks Act 1883 (UK), ss 18 (repealed), 19 (repealed), 20 (repealed) Federal Court Rules 2011 (Cth), rr 1.35, 25.14(3)
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate